Asia Pacific Biodefense Market size valued at USD 2.9 billion in 2021 and is projected to observe around 8.9% growth rate between 2022 and 2028.

Rising tension between nations across the globe, is one of the key factors driving the market growth. Similarly, increased defense spending by governments of several Asia Pacific countries to improve internal and external security is also propelling the market expansion.

Get more details on this report - Request Free Sample PDF

Innovative technologies such as gene chips for detecting pathogens are widely used in the biodefense-related nanotechnology, forensic medicine, and drug development. Government agencies identify various chemical, biological, nuclear, and radioactive threats and develop medical measures to minimize the adverse effects of these attacks. Apart from that, there is growing awareness of synthetic biology to improve agricultural yields, also has a positive impact on the market revenue.

 Asia Pacific Market, By Product

Get more details on this report - Request Free Sample PDF

The vaccines segment in the Asia Pacific biodefense market will exhibit a CAGR of 9% during the forecast period. The segmental growth is high as researchers are investigating new vaccine technologies, such as vector technology that guides rapid protection against pathogen attacks. These vaccines can target a wide range of biological agents and elicit a long-term immune response after a single oral dose. Further, many companies are competing for vaccine development due to the increase in Ebola virus, Zika virus, infections in some countries.

 Asia Pacific Market, By Country

China biodefense market revenue was over USD 800 million in 2021 and will grow at 9% CAGR through 2028. Factor such as the rising prevalence of infectious diseases, awareness about the availability of vaccines will augment the market expansion. Additionally, over the years, the country has researched potential biological warfare agents such as the causative agents of encephalitis, Q fever, plague, anthrax, tularemia, and psittacosis. The country possesses the technology to mass-produce most these traditional biological warfare agents.

Moreover, many players are using advanced technology to launch innovative bio-threat detection devices that help efficiently identify multiple viruses and bacteria. The market is further driven by the increasing demand for effective medical interventions and threat detection devices due to the rapid outbreak of the COVID 19 pandemic.

 Competitive Industry Landscape

Prominent players operating in the Asia Pacific biodefense market include Smiths Detection Group Ltd., Bavarian Nordic, Biosearch Technologies, Alexeter Technologies LLC, Bruker Detection, Electronic Sensor Technology Inc., Dynavax Technologies, Emergent BioSolutions, BioFire Defense (bioMérieux SA), Ichor Medical Systems, Inc., and Nanologix.

These companies have adopted various strategies such as product launches, collaborations, distribution agreements, and acquisitions that have helped them in sustaining the competition and gain significant position in the market.